|
2025
|
G/S
|
Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), gia... |
|
2024
|
G/S
|
Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in... |
|
|
Invention
|
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-... |
|
|
Invention
|
Methods of treating gastrointestinal stromal tumors.
The present disclosure relates to methods o... |
|
|
Invention
|
Dual raf and tubulin inhibitors and methods of use thereof. Described herein are compounds of for... |
|
|
Invention
|
Gcn2 and perk kinase modulators and methods of use thereof. Described herein are compounds of for... |
|
|
Invention
|
Combination therapy for the treatment of gastrointestinal stromal tumors.
The present disclosure... |
|
|
Invention
|
Gcn2 and perk kinase inhibitors and methods of use thereof.
Described herein are compounds that ... |
|
2023
|
Invention
|
Methods of treating gastrointestinal stromal tumors with ripretinib. The present disclosure relat... |
|
|
Invention
|
(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea. Provided here... |
|
|
Invention
|
Methods of treating melanoma with ripretinib.
The present disclosure relates to methods of treat... |
|
|
Invention
|
Methods of treating gastrointestinal stromal tumors. The present disclosure relates to methods of... |
|
|
Invention
|
Amorphous kinase inhibitor formulations and methods of use thereof.
Provided herein is an amorph... |
|
|
G/S
|
pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, sys... |
|
|
Invention
|
Methods of treating disorders with ulk inhibitors.
Described herein are compounds that are inhib... |
|
|
Invention
|
Combination of dcc-3116 and mapkap pathway inhibitors for use in the treatment of cancer. Describ... |
|
|
Invention
|
Ulk inhibitors and methods of use thereof.
Described herein are compounds that are inhibitors of... |
|
|
Invention
|
Ulk inhibitors and methods of use thereof. Described herein are compounds that are inhibitors of ... |
|
|
G/S
|
Pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, sys... |
|
|
Invention
|
Amorphous kinase inhibitor formulations and methods of use thereof. Provided herein is an amorpho... |
|
|
Invention
|
Methods of treating disorders using csf1r inhibitors.
Described herein are methods of treating c... |
|
|
Invention
|
Aminopyrimidine amide autophagy inhibitors and methods of use thereof.
Described herein are comp... |
|
2022
|
Invention
|
Raf kinase inhibitors and methods of use thereof.
Described herein are compounds that are RAF in... |
|
|
Invention
|
Raf kinase inhibitors and methods of use thereof. Described herein are compounds (I) that are RAF... |
|
|
Invention
|
Kit kinase inhibitors and methods of use thereof.
Described herein are compounds that are inhibi... |
|
|
Invention
|
Heterocyclic compounds as kit kinase inhibitors. Described herein are compounds of Formula I that... |
|
2021
|
G/S
|
Business administration of patient reimbursement programs; business administration of medication ... |
|
|
G/S
|
pharmaceutical research and development providing medical information to patients relating to the... |
|
2020
|
Invention
|
Methods for treating vascular malformations.
The present disclosure relates to methods for inhib... |
|
2019
|
G/S
|
Pharmaceutical oncology treatments, namely treatments for gastrointestinal stromal tumors, system... |
